Gilead Sciences, Inc. SEC filings GILD
Gilead Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Apr 2, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| N-PX | Filing | Aug 26, 2026 | Jun 30, 2026 |
| S-3ASR | Automatic shelf registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 20, 2026 | May 14, 2026 |
| 424B5 | Prospectus supplement | May 18, 2026 | — |
| FWP | Free writing prospectus | May 14, 2026 | — |
| 424B5 | Prospectus supplement | May 14, 2026 | — |
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2026 | Apr 28, 2026 |
| SC TO-T/A | Filing | Apr 28, 2026 | — |
| SC TO-T/A | Filing | Apr 17, 2026 | — |
| SC TO-T/A | Filing | Apr 1, 2026 | — |
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Apr 30, 2026 |
| SC TO-T | Filing | Mar 6, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| SC TO-C | Filing | Feb 23, 2026 | — |
| SC TO-C | Filing | Feb 23, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 23, 2026 | Feb 22, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2025 | Nov 15, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2025 | Oct 6, 2025 |
| N-PX | Filing | Aug 29, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2025 | Aug 10, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 4, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2025 | May 7, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 24, 2025 | Apr 24, 2025 |
| PX14A6G | Filing | Apr 7, 2025 | — |
| ARS | Annual report to shareholders | Mar 27, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 27, 2025 | — |
| DEF 14A | Proxy statement | Mar 27, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 12, 2025 | Mar 9, 2025 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 13, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| FWP | Free writing prospectus | Nov 13, 2024 | — |
| 424B5 | Prospectus supplement | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 9, 2024 | May 8, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 25, 2024 | Apr 25, 2024 |
| ARS | Annual report to shareholders | Mar 28, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEF 14A | Proxy statement | Mar 28, 2024 | May 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 22, 2024 | Mar 22, 2024 |
| SC TO-T/A | Filing | Mar 22, 2024 | — |
| SC TO-T/A | Filing | Mar 20, 2024 | — |
| PRE 14A | Preliminary proxy statement | Mar 18, 2024 | May 8, 2024 |
| SC TO-T/A | Filing | Mar 15, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2024 | Mar 10, 2024 |
| CORRESP | Letter to the SEC | Mar 11, 2024 | — |
| SC TO-T/A | Filing | Mar 11, 2024 | — |
| SC TO-T/A | Filing | Feb 28, 2024 | — |
| 10-K | Annual report | Feb 23, 2024 | Dec 31, 2023 |
| SC TO-T | Filing | Feb 23, 2024 | — |
| SC TO-C | Form sc to-c | Feb 14, 2024 | — |
| SC TO-C | Form sc to-c | Feb 12, 2024 | — |
| SC TO-C | Form sc to-c | Feb 12, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 12, 2024 | Feb 11, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Feb 1, 2024 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Sep 14, 2023 | Sep 14, 2023 |
| 424B5 | Prospectus supplement | Sep 11, 2023 | — |
| FWP | Free writing prospectus | Sep 7, 2023 | — |
| 424B5 | Prospectus supplement | Sep 7, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 16, 2023 | Aug 16, 2023 |
| S-8 | Employee stock plan registration | Aug 7, 2023 | — |
| S-3ASR | Automatic shelf registration | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 5, 2023 | May 3, 2023 |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 27, 2023 | Apr 27, 2023 |
| CORRESP | Letter to the SEC | Apr 25, 2023 | — |
| PX14A6G | Filing | Apr 6, 2023 | — |
| DEFR14A | Filing | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2023 | — |
| PX14A6G | Filing | Mar 29, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | — |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| 10-K | Annual report | Feb 22, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2023 | Feb 2, 2023 |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2022 | Sep 12, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Officer or director change
|
May 31, 2022 | May 25, 2022 |
| S-8 | Employee stock plan registration | May 5, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2022 | May 4, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2022 | Apr 28, 2022 |
| PX14A6G | Filing | Apr 11, 2022 | — |
| PX14A6G | Filing | Apr 7, 2022 | — |
| PX14A6G | Gilead sciences, inc | Apr 5, 2022 | — |
| DEFA14A | Additional proxy material | Mar 24, 2022 | — |
| DEF 14A | Proxy statement | Mar 24, 2022 | May 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2022 | Mar 7, 2022 |
| 10-K | Annual report | Feb 23, 2022 | Dec 31, 2021 |
| CT ORDER | Filing | Feb 2, 2022 | — |
| 8-K |
Current report
Results of operations
|
Feb 1, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2022 | Jan 5, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 28, 2021 | Oct 28, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2021 | Apr 29, 2021 |
| PX14A6G | Filing | Apr 19, 2021 | — |
| DEFA14A | Additional proxy material | Mar 30, 2021 | — |
| DEF 14A | Proxy statement | Mar 30, 2021 | May 12, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Jan 6, 2021 | Oct 23, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2020 | Dec 7, 2020 |
| S-8 | Employee stock plan registration | Nov 4, 2020 | — |
| 10-Q | Quarterly report | Nov 4, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2020 | Oct 28, 2020 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Oct 23, 2020 | Oct 23, 2020 |
| SC TO-T/A | Filing | Oct 23, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2020 | Oct 17, 2020 |
| SC TO-T/A | Filing | Oct 14, 2020 | — |
| SC TO-T/A | Filing | Oct 13, 2020 | — |
| SC TO-T/A | Filing | Oct 2, 2020 | — |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 30, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 29, 2020 | Sep 23, 2020 |
| 424B5 | Prospectus supplement | Sep 25, 2020 | — |
| SC TO-T/A | Filing | Sep 25, 2020 | — |
| SC TO-T | Filing | Sep 24, 2020 | — |
| SC TO-C | Form sc to-c | Sep 24, 2020 | — |
| FWP | Free writing prospectus | Sep 24, 2020 | — |
| 424B5 | Prospectus supplement | Sep 23, 2020 | — |
| SC TO-C | Form sc to-c | Sep 17, 2020 | — |
| SC TO-C | Form sc to-c | Sep 16, 2020 | — |
| SC TO-C | Form sc to-c | Sep 15, 2020 | — |
| SC TO-C | Form sc to-c | Sep 14, 2020 | — |
| SC TO-C | Form sc to-c | Sep 14, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 14, 2020 | Sep 13, 2020 |
| S-3ASR | Automatic shelf registration | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2020 | Jun 14, 2020 |
| S-8 | Employee stock plan registration | May 20, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2020 | May 6, 2020 |
| 10-Q | Quarterly report | May 6, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2020 | Apr 30, 2020 |
| DEFA14A | Additional proxy material | Apr 15, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| SC TO-T/A | Filing | Apr 7, 2020 | — |
| SC TO-T/A | Filing | Mar 30, 2020 | — |
| PX14A6G | Filing | Mar 26, 2020 | — |
| DEFA14A | Additional proxy material | Mar 24, 2020 | — |
| DEF 14A | Proxy statement | Mar 24, 2020 | May 6, 2020 |
| SC TO-T/A | Filing | Mar 23, 2020 | — |
| SC TO-T/A | Filing | Mar 17, 2020 | — |
| SC TO-T/A | Filing | Mar 12, 2020 | — |
| SC TO-T | Filing | Mar 10, 2020 | — |
| SC TO-C | Filing | Mar 3, 2020 | — |
| SC TO-C | Filing | Mar 2, 2020 | — |
| SC TO-C | Filing | Mar 2, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 2, 2020 | Mar 1, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2020 | Feb 4, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2020 | Jan 28, 2020 |
| CT ORDER | Filing | Jan 28, 2020 | — |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 24, 2019 | Oct 24, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2019 | Oct 15, 2019 |
| 8-K |
Current report
Other events
|
Aug 27, 2019 | Aug 23, 2019 |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2019 | Jul 30, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GILD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 882095
- Former names
- GILEAD SCIENCES INC (until Feb 17, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.